Radical Resection of Locally Recurrent Colorectal Cancer Significantly Improves Overall Survival: A Single-Center Cohort Study

被引:4
作者
Braun, Ruediger [1 ]
Bruch, Hans-Peter [1 ]
Keck, Tobias [1 ]
Benecke, Claudia [1 ]
Hoffmann, Martin [1 ]
机构
[1] Univ Med Ctr Schleswig Holstein, Dept Surg, Campus Lubeck,Ratzeburger Allee 160, DE-23538 Lubeck, Germany
关键词
Colorectal cancer; Recurrence; Surgery; Overall survival; Morbidity; Mortality; TOTAL MESORECTAL EXCISION; III COLON-CANCER; RECTAL-CANCER; CURATIVE RESECTION; PROGNOSTIC-FACTORS; PELVIC RECURRENCE; STAGE-II; SURGERY; FLUOROURACIL; OXALIPLATIN;
D O I
10.1159/000491099
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background: Despite multimodal treatment strategies, locoregional recurrence rates are still significant in colorectal carcinoma (CRC). Methods: Clinical, pathological, perioperative, and survival data of 203 patients with recurrent CRC enlisted in a prospective database from 1990 to 2011 were analyzed. Results: Median disease-free survival in our cohort of 203 patients was 23 months after resection of the primary tumor. In total, 113 of these patients had surgical therapy with resection of the recurrent tumor. The primary tumor was localized in the rectum in 63 (56%) patients and in the colon in 50 (44%) patients. A complete resection of the recurrent tumor (R0) was achieved in 69 (61%) patients. Postoperative complications occurred in 42 (37%) patients. Postoperative mortality was 2.7%. The median overall survival for R0-resected patients without distant metastasis was 91 months. Those patients had better overall survival compared to patients in whom no complete resection of the recurrent tumor was possible (p < 0.001). There was no statistically significant difference (overall survival) between patients that had R0-resection with systemic metastasis and R1 (p = 0.794) or R2 (p = 0.422) resection. Conclusion: Surgical resection of a locally recurrent CRC leads to a substantial long-term survival rate for R0-resected patients.
引用
收藏
页码:470 / 478
页数:9
相关论文
共 30 条
[1]   Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer [J].
Andre, T ;
Boni, C ;
Mounedji-Boudiaf, L ;
Navarro, M ;
Tabernero, J ;
Hickish, T ;
Topham, C ;
Zaninelli, M ;
Clingan, P ;
Bridgewater, J ;
Tabah-Fisch, I ;
de Gramont, A .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (23) :2343-2351
[2]  
[Anonymous], 2018, ANTI-CANCER DRUG, DOI [DOI 10.3322/caac.20115, DOI 10.1097/CAD.0000000000000617]
[3]   Rectal Cancer, Version 2.2015 Featured Updates to the NCCN Guidelines [J].
Benson, Al B., III ;
Venook, Alan P. ;
Bekaii-Saab, Tanios ;
Chan, Emily ;
Chen, Yi-Jen ;
Cooper, Harry S. ;
Engstrom, Paul F. ;
Enzinger, Peter C. ;
Fenton, Moon J. ;
Fuchs, Charles S. ;
Grem, Jean L. ;
Grothey, Axel ;
Hochster, Howard S. ;
Hunt, Steven ;
Kamel, Ahmed ;
Kirilcuk, Natalie ;
Leong, Lucille A. ;
Lin, Edward ;
Messersmith, Wells A. ;
Mulcahy, Mary F. ;
Murphy, James D. ;
Nurkin, Steven ;
Rohren, Eric ;
Ryan, David P. ;
Saltz, Leonard ;
Sharma, Sunil ;
Shibata, David ;
Skibber, John M. ;
Sofocleous, Constantinos T. ;
Stoffel, Elena M. ;
Stotsky-Himelfarb, Eden ;
Willett, Christopher G. ;
Gregory, Kristina M. ;
Freedman-Cass, Deborah .
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2015, 13 (06) :719-728
[4]   Outcomes and prognostic factors of multimodality treatment for locally recurrent rectal cancer with curative intent [J].
Bird, Thomas G. ;
Ngan, Samuel Y. ;
Chu, Julie ;
Kroon, Rene ;
Lynch, Andrew C. ;
Heriot, Alexander G. .
INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 2018, 33 (04) :393-401
[5]   Operative salvage for locoregional recurrent colon cancer after curative resection: An analysis of 100 cases [J].
Bowne, WB ;
Lee, B ;
Wong, WD ;
Ben-Porat, L ;
Shia, J ;
Cohen, AM ;
Enker, WE ;
Guillem, JG ;
Paty, PB ;
Weiser, MR .
DISEASES OF THE COLON & RECTUM, 2005, 48 (05) :897-909
[6]   Colorectal cancer [J].
Brenner, Hermann ;
Kloor, Matthias ;
Pox, Christian Peter .
LANCET, 2014, 383 (9927) :1490-1502
[7]   Prognostic factors after surgery for locally recurrent rectal cancer: An overview [J].
Caricato, M ;
Borzomati, D ;
Ausania, F ;
Valeri, S ;
Rosignoli, A ;
Coppola, R .
EJSO, 2006, 32 (02) :126-132
[8]   Curative potential of multimodality therapy for locally recurrent rectal cancer [J].
Hahnloser, D ;
Nelson, H ;
Gunderson, LL ;
Hassan, I ;
Haddock, MG ;
O'Connell, MJ ;
Cha, S ;
Sargent, DJ ;
Horgan, A .
ANNALS OF SURGERY, 2003, 237 (04) :502-508
[9]   Extended radical resection: The choice for locally recurrent rectal cancer [J].
Heriot, Alexander G. ;
Byrne, Christopher M. ;
Lee, Peter ;
Dobbs, Bruce ;
Tilney, Henry ;
Solomon, Michael J. ;
Mackay, John ;
Frizelle, Frank .
DISEASES OF THE COLON & RECTUM, 2008, 51 (03) :284-291
[10]   Prognostic factor research in oncology [J].
Hermanek, P .
JOURNAL OF CLINICAL EPIDEMIOLOGY, 1999, 52 (04) :371-374